P787: SABATOLIMAB (MBG453) COMBINATION TREATMENT REGIMENS FOR PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES: THE MYELODYSPLASTIC SYNDROMES STUDIES IN THE STIMULUS IMMUNO-MYELOID CLINICAL TRIAL PROGRAM

• A. M. Zeidan,
• A. Al-Kali,
• U. Borate,
• T. Cluzeau,
• A. E. DeZern,
• J. Esteve,
• A. Giagounidis,
• K. Kobata,
• R. Lyons,
• U. Platzbecker,
• D. A. Sallman,
• V. Santini,
• G. F. Sanz,
• M. A. Sekeres,
• A. H. Wei,
• Z. Xiao,
• M. Van Hoef,
• C. Nourry-Boulot,
• I. Sadek,
• F. Ma,
• A. Iordan,
• J. Sabo,
• G. Garcia-Manero

Affiliations

A. M. Zeidan

1 Yale University and Yale Cancer Center, New Haven

A. Al-Kali

2 Mayo Clinic, Rochester

U. Borate

3 Oregon Health & Science University, Portland, United States of America

T. Cluzeau

4 Centre Hospitalier Universitaire de Nice, Nice, France

A. E. DeZern

5 Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, United States of America

J. Esteve

6 Hospital Clinic, Barcelona, Spain

A. Giagounidis

7 Marien Hospital, Düsseldorf, Germany

K. Kobata

8 None, Los Angeles

R. Lyons

9 The US Oncology Network, San Antonio, United States of America

U. Platzbecker

10 University Hospital Leipzig, Leipzig, Germany

D. A. Sallman

11 H. Lee Moffitt Cancer Center & Research Institute, Tampa, United States of America

V. Santini

12 University of Florence, Florence, Italy

G. F. Sanz

13 Hospital Universitari i Politécnic La Fe; and CIBERONC, Instituto de Salud Carlos III, Valencia; Madrid, Spain

M. A. Sekeres

14 Sylvester Comprehensive Cancer Center, University of Miami, Miami, United States of America

A. H. Wei

15 Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia

Z. Xiao

16 Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China

M. Van Hoef

17 Novartis Pharma AG, Basel, Switzerland

C. Nourry-Boulot

17 Novartis Pharma AG, Basel, Switzerland

I. Sadek

18 Novartis Pharmaceuticals Corporation, East Hanover

F. Ma

18 Novartis Pharmaceuticals Corporation, East Hanover

A. Iordan

17 Novartis Pharma AG, Basel, Switzerland

J. Sabo

18 Novartis Pharmaceuticals Corporation, East Hanover

G. Garcia-Manero

19 MD Anderson Cancer Center, Houston, United States of America